Bariatric & obesity medicine prior authorization at Point32Health
PA workflow, documentation criteria, and peer-to-peer prep — for prescribers and PA staff
Point32Health bariatric & obesity medicine PA at a glance
Point32Health reviews bariatric & obesity medicine PA submissions against its medical policy library, with rules drawn primarily from AACE / ACE Obesity Management Algorithm + Obesity Society Position Statements. Point32Health-specific context: Formed by 2021 merger of Tufts Health Plan and Harvard Pilgrim Health Care; ~2M members across New England. Brands operate separately (Harvard Pilgrim, Tufts Health Plan). MA DOI primary regulator; MA OPP external review applies in Massachusetts.
Documentation packet — what to send
- BMI with date of measurement
- Comorbidity documentation (T2D, HTN, OSA, dyslipidemia, NAFLD)
- Lifestyle / behavioural intervention attempt (program + duration)
- Prior anti-obesity medication trials
- Pregnancy / breastfeeding status
Common denial patterns to pre-empt
Patterns observed in bariatric & obesity medicine across payers, and where Point32Health's book of business overlaps:
- Weight-loss exclusion in plan benefit (employer carve-out)
- BMI threshold above FDA label
- Comorbidity documentation (HTN, OSA, dyslipidemia) missing
- Step therapy through cheaper AOM first
- Lifestyle program participation not documented
- MA mandated benefit disputes
Appeal angles when Point32Health denies
- FDA label match (BMI ≥30, or BMI ≥27 with comorbidity)
- SURMOUNT / STEP trial citation
- Sleep study confirming OSA as comorbidity
- Documented prior lifestyle intervention with weight + duration
Peer-to-peer prep
- Quote the SURMOUNT-1 / SURMOUNT-3 / STEP trial results by name
- Document the lifestyle program with name and duration (e.g. Noom 6 months, in-person dietitian)
- Differentiate the diabetes vs obesity indication for semaglutide / tirzepatide explicitly
- Quote AACE Obesity Algorithm if the case is borderline
Drug-specific PA criteria at Point32Health
Deep dives on each drug's PA criteria at Point32Health:
Frequently asked questions
What documentation does Point32Health need for bariatric & obesity medicine prior authorizations?
Point32Health's PA packet for bariatric & obesity medicine typically includes: BMI with date of measurement; Comorbidity documentation (T2D, HTN, OSA, dyslipidemia, NAFLD); Lifestyle / behavioural intervention attempt (program + duration); Prior anti-obesity medication trials. AACE / ACE Obesity Management Algorithm + Obesity Society Position Statements citations strengthen the submission.
What's the turnaround at Point32Health?
Point32Health standard decision: 30 days. Expedited (urgent care): 72 hours per 45 CFR §147.136. Internal appeal window if denied: 180 days.
Which bariatric & obesity medicine drugs does Point32Health most often PA-restrict?
Top targets in bariatric & obesity medicine: semaglutide, tirzepatide, liraglutide. Each follows the per-drug step therapy + documentation requirements published in Point32Health's medical policy library.
How do I prep a peer-to-peer with Point32Health in bariatric & obesity medicine?
Quote the SURMOUNT-1 / SURMOUNT-3 / STEP trial results by name Document the lifestyle program with name and duration (e.g. Noom 6 months, in-person dietitian) Have the policy URL and the patient's chart open before the call.
Generate a Bariatric & obesity medicine PA packet
Open ApprovalHelp — generate a bariatric & obesity medicine PA packet tailored to Point32Health's criteria, with prescriber attestation and supporting citations pre-filled.
Get started →Contact: hello@approvalhelp.com